PRCT
PROCEPT BioRobotics Corporation
NASDAQ · Healthcare · Medical - Devices · US
$22.76
+6.50%Margins
Gross margin
63.7%
EBITDA margin
-29.3%
EBIT margin
-33.9%
Net margin
-32.5%
FCF margin
-37.3%
-32.3%
Return on equity
-22.9%
Return on assets
-27.4%
Return on invested capital
0.70x
Asset turnover
-$112.5M
Cash from operations
$3.98
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026